Emirates Drug Establishment (EDE), the federal medicines regulator
Is Cagrilintide (and CagriSema) legal in United Arab Emirates?
Not approvedNo EDE approval found for cagrilintide or CagriSema; not marketed in the UAE
Not approved as a medicine here.
Cagrilintide is an amylin-type medicine being developed by Novo Nordisk, alone and combined with semaglutide as CagriSema. I found no EDE approval announcement for either. Under Federal Decree-Law 38/2024 no medical product may be circulated or sold in the UAE without EDE marketing approval, and the sources I checked show no EDE approval for it. It cannot lawfully be marketed without that approval, and I found no UAE marketing notice for it.
Last verified 2026-09-29 · how we verify
Cagrilintide (and CagriSema) elsewhere
Sources (3)
- 01Pharmaceutical licensing and drug registration in the UAE (Federal Decree-Law 38 of 2024)Kayrouz and Associates · 2026-03-18 · accessed 2026-09-29
- 02Federal Decree-Law No. (38) of 2024 on Medical Products, the Pharmacy Profession and Pharmaceutical Establishments (Arabic text)Emirates Drug Establishment (EDE) · 2024-10-01 · accessed 2026-09-29
- 03Legislations (Federal Decree-Law 38/2024 and other instruments)Emirates Drug Establishment (EDE) · 2026-09-29 · accessed 2026-09-29